Hypercalcemia - Mechanisms, differential diagnosis, and remedies

被引:10
作者
Deftos, LJ [1 ]
机构
[1] VET AFFAIRS MED CTR, ENDOCRINE RES LAB, LA JOLLA, CA USA
关键词
D O I
10.3810/pgm.1996.12.130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The urgency for treatment of hypercalcemia is assessed by determining the severity of symptoms and complications and the degree of elevation of serum calcium. Increased bone resorption is the most common pathophysiologic mechanism for hypercalcemia, and several agents are used to inhibit this resorption, including calcitonin and bisphosphonates. However, inhibition of bone resorption controls hypercalcemia for only a limited time, and prompt definitive treatment of the underlying cause, such as primary hyperparathyroidism or malignancy, is essential.
引用
收藏
页码:119 / +
页数:1
相关论文
共 9 条
[1]   PARATHYROID HORMONE-RELATED PEPTIDE IN SICKNESS AND IN HEALTH [J].
BILEZIKIAN, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (16) :1151-1153
[2]   HYPERCALCEMIA OF ADVANCED MALIGNANCY - DECISION-MAKING AND THE QUALITY OF DEATH [J].
BOISAUBIN, EV ;
LYNCH, GR ;
DRESSER, R .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1991, 301 (05) :314-318
[3]   ALL MAJOR LUNG-CANCER CELL-TYPES PRODUCE PARATHYROID HORMONE-LIKE PROTEIN - HETEROGENEITY ASSESSED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BRANDT, DW ;
BURTON, DW ;
GAZDAR, AF ;
OIE, HE ;
DEFTOS, LJ .
ENDOCRINOLOGY, 1991, 129 (05) :2466-2470
[4]  
BURTIS WJ, 1992, CLIN CHEM, V38, P2171
[5]   HYPERCALCEMIC CRISIS [J].
EDELSON, GW ;
KLEEREKOPER, M .
MEDICAL CLINICS OF NORTH AMERICA, 1995, 79 (01) :79-92
[6]   HUMORAL HYPERCALCEMIA OF MALIGNANCY - SOME ENIGMAS ON THE CLINICAL-FEATURES [J].
IKEDA, K ;
OGATA, E .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, 57 (03) :384-391
[7]   PARATHYROID HORMONE-RELATED PROTEIN [J].
MOSELEY, JM ;
GILLESPIE, MT .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1995, 32 (03) :299-343
[8]   MEDICAL-MANAGEMENT OF HYPERCALCEMIA [J].
RALSTON, SH .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (01) :11-20
[9]   OPTIMAL FREQUENCY OF ADMINISTRATION OF PAMIDRONATE IN PATIENTS WITH HYPERCALCEMIA OF MALIGNANCY [J].
WIMALAWANSA, SJ .
CLINICAL ENDOCRINOLOGY, 1994, 41 (05) :591-595